Tags

Type your tag names separated by a space and hit enter

Questionable benefit of melatonin for antioxidant pharmacologic therapy.
J Clin Oncol. 2002 Oct 01; 20(19):4127-8; author reply 4128-9.JC

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comment
Letter

Language

eng

PubMed ID

12351615

Citation

Wölfler, Albert, et al. "Questionable Benefit of Melatonin for Antioxidant Pharmacologic Therapy." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 20, no. 19, 2002, pp. 4127-8; author reply 4128-9.
Wölfler A, Abuja PM, Linkesch W, et al. Questionable benefit of melatonin for antioxidant pharmacologic therapy. J Clin Oncol. 2002;20(19):4127-8; author reply 4128-9.
Wölfler, A., Abuja, P. M., Linkesch, W., Schauenstein, K., & Liebmann, P. M. (2002). Questionable benefit of melatonin for antioxidant pharmacologic therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 20(19), 4127-8; author reply 4128-9.
Wölfler A, et al. Questionable Benefit of Melatonin for Antioxidant Pharmacologic Therapy. J Clin Oncol. 2002 Oct 1;20(19):4127-8; author reply 4128-9. PubMed PMID: 12351615.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Questionable benefit of melatonin for antioxidant pharmacologic therapy. AU - Wölfler,Albert, AU - Abuja,Peter M, AU - Linkesch,Werner, AU - Schauenstein,Konrad, AU - Liebmann,Peter M, PY - 2002/9/28/pubmed PY - 2002/11/26/medline PY - 2002/9/28/entrez SP - 4127-8; author reply 4128-9 JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology JO - J Clin Oncol VL - 20 IS - 19 SN - 0732-183X UR - https://www.unboundmedicine.com/medline/citation/12351615/Questionable_benefit_of_melatonin_for_antioxidant_pharmacologic_therapy_ DB - PRIME DP - Unbound Medicine ER -